NFKB1 and central nervous system cancer: In our previous study, we showed that RIP2 expression increased in gliomas; additionally, findings from in vitro studies indicated that RIP2 could activate the NF‐κB and p38 signaling pathways and subsequently influence the biological behavior of malignant gliomas.23